Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 201 - 220 of 512 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of FOLFOX plus Regorafenib in Patients with Inoperable or Metastatic Esophageal and/or Stomach Cancer
[Protocol 13-080]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Nintedanib in Patients with Advanced Esophagogastric Cancer
[Protocol 14-094]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Regorafenib versus Placebo in Patients with Node-Positive Esophageal Cancer Who Completed Chemotherapy, Radiation Therapy, and Surgery
[Protocol 14-169]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
[Protocol 13-066]
Jarnagin, William
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Actinomycin-D versus Methotrexate to Treat Low-Risk Gestational Trophoblastic Disease
[Protocol 13-108]
Jewell, Elizabeth
  • Uterine (Endometrial) Cancer
A Study Assessing the Safety and Tolerability of Supervised Aerobic Exercise Training in Women with Metastatic Breast Cancer
[Protocol 14-170]
Jones, Lee
  • Breast Cancer
  • Quality of Life
A Pilot Study of NovoTTF-100A for Recurrent Atypical or Anaplastic Meningioma
Relapsed/Refractory
[Protocol 13-067]
Kaley, Thomas
  • Brain Tumors, Primary
    • Other Trials
A Phase I Study of MK-1775 with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma
Newly Diagnosed
[Protocol 13-161]
Kaley, Thomas
  • Brain Tumors, Primary
    • Gliomas
Early Onset and Familial Gastric Cancer Registry
[Protocol 05-118]
Kelsen, David
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy
  • Colorectal Cancer
Defibrotide for Patients with Hepatic Veno-Occlusive Disease
[Protocol 08-060]
Kernan, Nancy
  • Blood and Marrow Transplantation
    • Transplantation
A Phase II Study of Pegylated Interferon Alfa-2b (PEGIntron) in Children with Inoperable Craniopharyngioma After Prior Therapy
Relapsed/Refractory
[Protocol 14-037]
Khakoo, Yasmin
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase III Study Evaluating of the Role of Axillary (Armpit) Lymph Node Removal in Patients with Breast Cancer with Positive Sentinel Lymph Nodes after Preoperative Chemotherapy
Newly Diagnosed
[Protocol 14-151]
King, Tari
  • Breast Cancer
A Study Assessing the Influence of Breast MRI Before Lumpectomy on Outcomes, Quality of Life, and Costs in Women with Breast Cancer
Newly Diagnosed
[Protocol 14-198]
King, Tari
  • Breast Cancer
  • Quality of Life
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190]
King, Tari
  • Breast Cancer
A Phase II Study of Selinexor (KPT-330) in Patients with Persistent Myelodysplastic Syndromes
[Protocol 14-005]
Klimek, Virginia
  • Hematology
    • Myelodysplastic Syndrome
Treatment of Children with All Stages of Hepatoblastoma
[Protocol 10-046]
Kobos, Rachel
  • Hepatobiliary
    • Liver Cancer
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014]
Kobos, Rachel
  • Kidney Cancer
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
Relapsed/Refractory
[Protocol 12-175]
Koehne, Guenther
  • Hematology
    • Multiple Myeloma
A Phase II Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051]
Koehne, Guenther
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Hematology
    • Multiple Myeloma